A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides
- 1 August 2004
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 99 (1) , 139-155
- https://doi.org/10.1016/j.jconrel.2004.06.009
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotidesBiochemical Pharmacology, 2003
- The Efficacy of Small Interfering RNAs Targeted to the Type 1 Insulin-like Growth Factor Receptor (IGF1R) Is Influenced by Secondary Structure in the IGF1R TranscriptJournal of Biological Chemistry, 2003
- Antisense oligonucleotides selected by hybridisation to scanning arrays are effective reagents in vivoNucleic Acids Research, 2001
- The cellular delivery of antisense oligonucleotides and ribozymesDrug Discovery Today, 2001
- The delivery of antisense therapeuticsAdvanced Drug Delivery Reviews, 2000
- The folding of large RNAs studied by hybridization to arrays of complementary oligonucleotidesRNA, 1999
- Antisense Pharmacodynamics: Critical Issues in the Transport and Delivery of Antisense OligonucleotidesPharmaceutical Research, 1999
- Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinaseNature Medicine, 1996
- Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide librariesNucleic Acids Research, 1996
- Cellular uptake and intracellular fate of antisense oligonucleotidesTrends in Cell Biology, 1992